scholarly journals Antidiabetic Potential of Selected Medicinal Plants: A Literature Review

2021 ◽  
pp. 1-11
Author(s):  
Abdulrahman Altalhi ◽  
Mashhour Alsufyani ◽  
Khalid Alqurashi ◽  
Hussain Alshalwi ◽  
Abdullah Althobaiti ◽  
...  
Keyword(s):  
Plant Species ◽  
Scientific Evidence ◽  
Tolerance Test ◽  
Protein Glycation ◽  
Antidiabetic Activity ◽  
In Vivo Evaluation ◽  
Traditional Use ◽  
Alpha Glucosidase

Aims: To investigated for any scientific evidence indicating traditional use of different plant species in the management of diabetes. Study Design: Review Article. Place and Duration of Study: Conducted in Saudi Arabia from December 2020 to August 2021. Methodology: The literature was thoroughly investigated for any scientific evidence indicating traditional use of different plant species in the management of diabetes. The search was done in databases of Google Scholar, Saudi Digital Library and PubMed. Accordingly, the used plant species are classified into six groups. These are: Plants with antidiabetic activity, Plants with hypoglycemic activity, plants with alpha-glucosidase activity, Plants with alpha-amylase activity, Plants with glucose tolerance test, Plants with hypolipemic, anti-cholesterol, LDL and HDL activity. Conclusion: We have done in vitro and in vivo evaluation of M. arvensis L. for antidiabetic activity.  The leaves extracts of M. arvensis L. showed significant antioxidant potential and significantly inhibited protein glycation, which correlated well with its phenolics along with other phytoconstituents. the methanolic extract of M. arvensis L.

scholarly journals Bornyl Derivatives of p-(Benzyloxy)Phenylpropionic Acid: In Vivo Evaluation of Antidiabetic Activity

2020 ◽  
Vol 13 (11) ◽  
pp. 404
Author(s):  
Sergey Kuranov ◽  
Olga Luzina ◽  
Mikhail Khvostov ◽  
Dmitriy Baev ◽  
Darya Kuznetsova ◽  
...  
Keyword(s):  
Computational Prediction ◽  
Tolerance Test ◽  
Antidiabetic Activity ◽  
Oral Glucose ◽  
In Vivo Evaluation ◽  
Phenylpropionic Acid ◽  
Biological Targets ◽  
Lipid Metabolism Disorders ◽  
Derivatives Of

A series of bornyl derivatives of p-(benzyloxy)phenylpropionic acid were prepared, and their hypoglycemic activities were examined by an oral glucose tolerance test in mice. The results of this test revealed two compounds, 1 and 3, that can reduce the blood level of glucose similarly to reference compound vildagliptin. Both compounds were tested in an experiment on mice with metabolic disorders: the C57BL/6Ay strain. Along with hypoglycemic properties, the two compounds showed different abilities to correct lipid metabolism disorders. In silico prediction revealed that the studied substances are most likely bifunctional multitarget hypoglycemic compounds whose mechanism of action is based on a pronounced reduction in insulin resistance and a strong incretin-mimetic effect. The difference in the size of effects of these compounds on biochemical parameters of blood in the experiment on C57BL/6Ay mice was in good agreement with the computational prediction of the priority ranking of biological targets for these compounds. These results indicate that bornyl derivatives of p-(benzyloxy)phenylpropionic acid have a good potential as new agents for diabetes mellitus treatment due to their hypoglycemic and lipid-normalizing properties.

scholarly journals Assessment of In Vitro Antidiabetic Potential of Purified Anthocyanin Extract from Floral Petals of Wild Balsam Species

2020 ◽  
Vol 10 (3) ◽  
pp. 31-35
Author(s):  
R ARATHY ◽  
K MURUGAN ◽  
KV DINESH BABU ◽  
GS MANOJ
Keyword(s):  
International Diabetes Federation ◽  
Inhibitory Effect ◽  
Alpha Amylase ◽  
Herbal Remedies ◽  
Antidiabetic Activity ◽  
Public Health Issue ◽  
Impatiens Balsamina ◽  
Alpha Glucosidase

Diabetes is a notorious and growing clinical and public health issue. The International Diabetes Federation assumes that 592 million had diabetes by 2035 and that by 2040 the number will increase to 642 million. Cardiovascular corollary accounts for four million deaths annually attributable to diabetes. Evidence reveals that certain glucose-lowering phytochemicals can improve vascular outcomes with type 2 diabetes, which, together with better understanding of using multiple therapies concurrently, offers opportunities for beneficial personalization of medication regimens. Anthocyanins are coloured pigments and are natural antioxidants. Keeping this in focus, this study was undertaken to evaluate the in vitro antidiabetic activity in the petals of wild Impatiens balsamina L. The anthocyanin was extracted from floral petals of wild balsam species and purified to homogeneity using chromatographic techniques. Evaluation of in vitro antidiabetic properties of anthocyanin extract revealed a dose-dependent increase in the inhibitory effect on the alpha-glucosidase (200 μg/ml) and alpha-amylase enzymes (500 μg/ml) and was comparable with the standard acarbose drug (189 μg/ml and 50 μg/ml). These results indicated that anthocyanin could be used as a source of functional food and nutraceuticals. This information from wild species will be useful in finding more potent antidiabetic principle from the natural resources for the clinical development of antidiabetic therapeutics. Future studies are planned to substantiate the antidiabetic power of anthocyanin using in vivo animal models. Keywords: Alpha amylase, alpha glucosidase, diabetes, herbal remedies, Impatiens balsamina L.

scholarly journals Hypoglycemic Effect of Calea urticifolia (Mill.) DC.

2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
Adolfo Andrade-Cetto ◽  
Fernanda Espinoza-Hernández ◽  
Gerardo Mata-Torres
Keyword(s):  
Plant Extract ◽  
Tolerance Test ◽  
Glucose Absorption ◽  
Hypoglycemic Effect ◽  
Network Pharmacology ◽  
Traditional Use ◽  
Hepatic Glucose ◽  
Glucose Output

The onset of type 2 diabetes (T2D) is a consequence of the progressive loss of adequate β-cell insulin secretion, which frequently occurs under a background of insulin resistance. Currently, nearly 13 million Mexicans are living with diabetes. Moreover, due to poor socioeconomic conditions and the cultural idiosyncrasies of the Mexican population, the use of medicinal plants to treat T2D is a common practice in Mexico. In the Mexican state of Hidalgo, we found the traditional use of Calea urticifolia (CU) to treat this disease. To treat T2D, people drink an infusion made from the aerial part of the plant throughout the day. With the aim of investigating whether the infusion at a traditional dose produces a hypoglycemic effect in either the fasting or postprandial state, we measured the effect of the infusion in a hyperglycemic animal model (rats administered streptozotocin (STZ) and nicotinamide (NZ)) by conducting a glucose tolerance test and constructing a blood-glucose curve. We then analyzed whether the observed effect was related to the inhibition of glucose absorption in the gut or the inhibition of hepatic glucose output (HGO) in vivo and in vitro. Furthermore, we confirmed our findings by identifying the potential targets of the infusion via a network pharmacology analysis. Through high-performance liquid chromatography (HPLC) and thin layer chromatography (TLC), we detected a number of compounds in the extract and identified two of them. The plant extract produced a highly significant hypoglycemic effect under fasting conditions and a weak hypoglycemic effect following glucose or sucrose challenge. Although the plant extract blocked only 20% of the alpha-glucosidase enzyme activity in vitro, in the pyruvate tolerance test (which measures the liberation of hepatic glucose), it significantly reduced glucose levels. Furthermore, in vitro, the extract diminished the activity of the glucose-6-phosphatase complex by 90%. In addition, by conducting TLC, we detected the presence of chlorogenic acid and rutin, which have been reported to block HGO. The results presented here provide evidence of the hypoglycemic effect of the traditionally used C. urticifolia extract and demonstrate that this effect is associated with both a reduction in glucose synthesis via gluconeogenesis due to the phytochemical composition of the extract and a slight blockage of glucose absorption in the gut.

scholarly journals A Review of the Potential Benefits of Plants Producing Berries in Skin Disorders

Antioxidants ◽  
2020 ◽  
Vol 9 (6) ◽  
pp. 542 ◽  
Author(s):  
Stefano Piazza ◽  
Marco Fumagalli ◽  
Saba Khalilpour ◽  
Giulia Martinelli ◽  
Andrea Magnavacca ◽  
...  
Keyword(s):  
Inflammatory Responses ◽  
Scientific Evidence ◽  
Punica Granatum ◽  
Extraction Methods ◽  
Vitis Vinifera L ◽  
Traditional Use ◽  
Potential Benefits ◽  
Definition Of

During the last 30 years, berries have gained great attention as functional food against several risk factors in chronic diseases. The number of related publications on Pubmed rose from 1000 items in 1990 to more than 11,000 in 2019. Despite the fact that a common and clear definition of “berries” is not shared among different scientific areas, the phytochemical pattern of these fruits is mainly characterized by anthocyanins, flavanols, flavonols, and tannins, which showed antioxidant and anti-inflammatory properties in humans. Skin insults, like wounds, UV rays, and excessive inflammatory responses, may lead to chronic dermatological disorders, conditions often characterized by long-term treatments. The application of berries for skin protection is sustained by long traditional use, but many observations still require a clear pharmacological validation. This review summarizes the scientific evidence, published on EMBASE, MEDLINE, and Scholar, to identify extraction methods, way of administration, dose, and mechanism of action of berries for potential dermatological treatments. Promising in vitro and in vivo evidence of Punica granatum L. and Vitis vinifera L. supports wound healing and photoprotection, while Schisandra chinensis (Turcz.) Baill. and Vaccinium spp. showed clear immunomodulatory effects. Oral or topical administrations of these berries justify the evaluation of new translational studies to validate their efficacy in humans.

scholarly journals ETHYLCELLULOSE FLOATING MICROSPHERES OF ANTIDIABETIC AGENT: IN VITRO AND IN VIVO EVALUATION

2016 ◽  
Vol 9 (1) ◽  
pp. 44 ◽  
Author(s):  
Seema Kohli ◽  
Megha Sharma ◽  
Abhisek Pal
Keyword(s):  
Average Particle Size ◽  
Insulin Dependent Diabetes Mellitus ◽  
Treated Group ◽  
Antidiabetic Activity ◽  
Dependent Diabetes Mellitus ◽  
Average Particle ◽  
In Vivo Evaluation ◽  
Gastro Retentive

Objective: To develop and evaluate floating type gastro-retentive dosage form, appropriate for controlled release of repaglinide (RG) having a narrow therapeutic window.Methods: Repaglinide loaded microspheres (MS) using biological macromolecule ethylcellulose (EC) was prepared by a solvent diffusion-evaporation technique using polyvinyl alcohol (PVA) emulsifier. Compatibility of drug and polymer was studied by Fourier-transform infrared spectroscopy (FTIR). During formulation, various process optimisation parameters studied were stirring speed, the concentration of drug, polymer and emulsifier. Characterization and in vitro evaluation was performed. In vivo antidiabetic activity was performed on alloxan induced diabetic rats followed by histopathological screening.Results: The average particle size was in the range of 174-243 µm. Yield, entrapment and buoyancy of microspheres were 68.4­­-79.8, 58.6-73.1 and 71.8-84.1% respectively. 65.1% release of drug from optimised formulation was obtained which follows first-order kinetics (r2 = 0.989). Optimised formulation treated group shows significant (p<0.01) decrease in glucose level of blood as compared to pure drug treated group during the later hours of study with satisfactory results of histology.Conclusion: The investigation revealed the promising potential of gastro retentive microspheres for delivering RG for the treatment of non-insulin dependent diabetes mellitus (NIDDM).

Towards a modern approach to traditional use: in vitro and in vivo evaluation of Alchemilla vulgaris L. gel wound healing potential

2019 ◽  
Vol 238 ◽  
pp. 111789 ◽  
Author(s):  
Marija Tasić-Kostov ◽  
Ivana Arsić ◽  
Dragana Pavlović ◽  
Sanja Stojanović ◽  
Stevo Najman ◽  
...  
Keyword(s):  
Wound Healing ◽  
In Vivo Evaluation ◽  
Traditional Use ◽  
Modern Approach

In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives

2014 ◽  
Vol 80 ◽  
pp. 502-508 ◽  
Author(s):  
Pan-Pan Wu ◽  
Kun Zhang ◽  
Yu-Jing Lu ◽  
Ping He ◽  
Su-Qing Zhao
Keyword(s):  
Ursolic Acid ◽  
Antidiabetic Activity ◽  
In Vivo Evaluation

scholarly journals Bioactivities of extracts and phytochemicals of Indigofera aspalathoides Vahl ex DC.

2021 ◽  
pp. 1-16
Keyword(s):  
Plant Species ◽  
Web Of Science ◽  
Scientific Evidence ◽  
Anticancer Compounds ◽  
Traditional Medicines ◽  
Anti Inflammatory ◽  
Phytochemical Studies ◽  
The Web

Indigofera aspalathoides Vahl ex DC. belongs to the Fabaceae family. I. aspalathoides is applied to heal tumors, inflammations, diabetes, leprosy, and kidney illnesses in traditional medicines. Compounds including kaempferol, kaempferol 5-O-β-D-glucopyranoside, 5,4'-dihydroxy 6,8-dimethoxy 7-O-rhamnosyl flavone, indigocarpan, and mucronulatol have isolated from this plant species. Hitherto, there is no comprehensive review available regarding the reported bioactivities of I. aspalathoides. Thus, this article goals to analyze, summarize and document the published bioactivities-related publications. Electronic databases the Web of Science, Scopus, ScienceDirect, and PubMed used to find relevant publications from 1900 to December 2020. Thus far, only in vivo and in vitro scientific evidence levels of bioactivities are available. I. aspalathoides holds such as anti-inflammatory, anticancer, antihepatotoxic, anti-arthritic, immunomodulatory, and antidiabetic properties. Overall, immunomodulatory, anti-inflammatory, and anticancer compounds have been isolated from this plant species Therefore, additional bioactivity and phytochemical-related researches would need to perform to generate more scientific evidence for other applications. This work will be useful for further bioactivity and phytochemical studies using this plant species.

scholarly journals Preliminary Analysis of the Antidiabetic Activity of Indonesian Polyherbal Formulation

2021 ◽  
Vol 21 (3) ◽  
pp. 219
Author(s):  
Syamsudin Abdillah ◽  
Apriala Gita Lestari ◽  
Priskila Monika ◽  
Wahono Sumaryono ◽  
Kartiningsih Hisyam
Keyword(s):  
Stevia Rebaudiana ◽  
Inhibitory Effect ◽  
Antidiabetic Activity ◽  
Smallanthus Sonchifolius ◽  
Polyherbal Formulation ◽  
Diabetes In Mice ◽  
Ethanol Extracts ◽  
Alpha Glucosidase

This study aims to prepare polyherbal formulations and also analyze the antidiabetic potentials of the prepared polyherbal in animals. The ethanol extracts of the leaves of <em>Smallanthus sonchifolius</em>, <em>Stevia rebaudiana, Syzygium polyanthum</em>, and <em>Camellia sinensis</em> were used in this study. The extracts of the aforementioned plants were prepared in the ratio of 2:1:1:1. The formulation was tested for antidiabetic activity <em>in vitro</em> through the inhibition of alpha-glucosidase and <em>in vivo</em> using alloxan-induced diabetes in mice. The polyherbal has an inhibitory effect with the IC<sub>50</sub> value of 26.23 μg/mL compared to acarbose (control) was 17.02 μg/mL. The diabetic animals were observed to show an obvious decline in glucose level when compared with control (P&lt; 0.001) after treatment.

Sign in / Sign up

Export Citation Format

Share Document